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The H-2-1inked immune response-1  (It-l) 1 gene controls murine antibody responses 
to the synthetic polypeptide poly-L(Tyr,Glu)-poly-D,L-Ala--poly-L-Lys  [(T,G)-A--L] 
(1). It was demonstrated in the preceding paper, using immunization with antigen in 
aqueous  solution,  that  both  high responder  (H-2 b)  and low  responder  (//-2  k)  mice 
produce equal levels of IgM anti-(T, G)-A--L antibody after a primary antigen chal- 
lenge (2). With secondary and tertiary challenges, however, only the high responder 
strain develops immunologic memory, producing high titers of IgG antibody. These 
studies suggested that the it-1 gene effect is exerted during the induction of IgG anti- 
body formation. Furthermore, in earlier studies utilizing a regimen of immunization 
with antigen in complete Freund's adjuvant (CFA) followed by a secondary challenge 
with aqueous antigen, it was shown that: (a) low responder (nonresponder) mice will 
produce high titers of anti-(T,G)-A--L antibody if the immunization is carried out 
with  the  (T,G)-A--L complexed with  a  "carrier" protein,  e.g.,  methylated bovine 
serum albumin (MBSA) ; (b) nonresponder mice immunized with MBSA-(T, G)-A--L 
produce approximately the  same  numbers  of  anti-(T,G)-A--L antibody-producing 
cells as do responder mice immunized with (T, G)-A--L or MBSA-(T, G)-A--L (utiliz- 
ing a modified hemolytic plaque-forming cell assay iF. C. Grumet, unpublished obser- 
vation]) ; (c)  the anti-(T, G)-A--L secondary antibody response is thymus dependent, 
i.e., is greatly reduced in  thymectonlized mice  (3,  4).  Two  important concepts  are 
implied by the above body of data: first, responder and nonresponder mice are both 
capable of synthesizing anti-(T, G)-A--L antibody molecules, and, second, the immune 
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defect in the nonresponders appears to be a faulty or incomplete specific recognition 
mechanism for the antigen under discussion. 
It is,  therefore,  not unreasonable to postulate that the It-1  gene effect  may be 
exerted at the level of a thymus-derived "T"-cell, rather than by an antibody-produc- 
ing "B"-cell (5). A minimum  prediction of such a postulate would be that thymectomy 
would convert responder mice into a nonresponder pattern of anti-(T,  G)-A--L anti- 
body formation, without affecting the antibody response pattern of the nonresponders. 
Responses to many other antigens, such as bovine serum albumin (BSA) and 
sheep red cells (SRBC) appear to be similarly thymus dependent. For a number 
of these antigens, thymectomy appears to depress the secondary or IgG anti- 
body response much more than the primary or IgM response (6-11). This effect 
is similar to the defective IgG formation seen in the (T, G)-A--L nonresponder 
mice.  The  present study,  therefore,  was  undertaken to  evaluate the  role  of 
thymectomy in  (T, G)-A--L responder  and  nonresponder mice.  The  results 
showed that thymectomy blocked IgG anti-(T, G)-A--L antibody formation in 
response to either  (T,G)-A--L or MBSA-(T,G)-A--L, but did not block the 
IgM response. 
Materials and Methods 
Mice.--Male  mice of  the  strains  C3H/HeJ  (H-2k),  C57BL/10Sn  (H-2b), and CBA/J 
(H-2 k) were purchased from the Jackson Laboratory,  Bar Harbor,  Maine;  C3H.SW/SnHz 
(H-2  b, Ig-P) mice  and their immunoglobulin allotype congenic partner CWB/8 (H-Z  °, Ig-1  b) 
were obtained from the colony of Dr. L. A. Herzenberg, Department of Genetics, Stanford 
University.  (The  latter  two  strains  of  mice are  congenic with  the  strain  C3H/DiSn 
[tt-2 k, Ig-lol.) 
Thymectomy.--Neonatal  or young adult mice were thymeetomized using the suction method 
devised originally by Miller  (12). All thymus areas of thymectomized mice were checked 
macroscopically for the presence of thymus remnants at the completion of the experiments. 
Antigens, Immunization  Procedures, and Antibody Determinatiom.--Yrevious  publications 
from this laboratory  have described the preparation  of  (T,G)-A--L in CFA or phosphate- 
buffered saline (PBS), the collection of plasma, antibody determinations using rabbit anti- 
mouse "y-globulin  sera and (T,G)-A--L 509-I~5I in a modified Farr assay, and 2-mercapto- 
ethanol  (2-Me) reduction of antisera  (2, 13). As in the preceding paper, antibody titers are 
expressed as per cent antigen  bound at a particular serum dilution. MBSA was purchased from 
Nutritional Biochemicals Corporation, Cleveland, Ohio, and the MBSA-(T,G)-A--L complex 
was prepared as previously described (3). 
Irradiation.--Mice  were irradiated in a circular plastic box with individual compartments 
using a Siemens X-ray machine (Siemens Corp., Electromedical Div., Iselin, N.J.)  (in the 
Department of Radiobiology at Stanford) operating under conditions of 250 kv, 15 ma, 0.25 
mm Cu plus 1.0 mm Al and a half-value layer of 1.10 mm Cu. The dose rate was 80 fads/rain 
with a focal skin distance of 60 cm. 
Preparation of CeUs.--Single cell suspensions were prepared by disrupting organs over 50- 
mesh stainless steel screen in minimal essential medium (MEM-PM). 2 Bone marrow plugs 
s MEM-PM =  minimal essential medium (Eagle) purchased from Grand Island Biological 
Co., Grand Island, N.Y. Instant tissue culture medium powder without NaHCO~ was made 
up with Na2HPO4.12H~O (0.001 ~) and MgClw 6H20 (0.001 ~), instead of bicarbonate, in 
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were flushed from femoral and tibial cavities using MEM-PM, and were disrupted by aspira- 
tion through a Pasteur pipette. Cells for counting were suspended in filtered 0.37% formalde- 
hyde-saline solution containing 0.1  mg/ml saponin (Coulter Electronics Inc., Hialeah, Fla.) 
and counts were performed using a precalibrated Coulter counter, Model B, fitted with a 100 ll 
aperture. 
RESULTS 
Influence of Adult Thymectomy Combined  with Irradiation on the Primary and 
Secondary Response to Aqueous (T,G)-A--L.--Male mice of the C3H/HeJ and 
C3H.SW/SnHz strains were thymectomized or sham-thymectomized at 5-8 wk 
of age. 18 days later, they were X-irradiated with a dose of 750 rads and injected 
with 4.7 million syngeneic bone marrow cells intravenously. 28 days after irra- 
diation, groups of three or four mice were injected intraperitoneally with 10 or 
100 #g (T, G)-A--L 52 in PBS and bled at various times from 4 to 51 days later. 
Secondary and tertiary challenges of antigen in PBS were given on days 7 and 
39.  The mean plasma antibody titers are presented in Figs.  1 a,  1 b,  2 a,  and 
2 b. No significant differences in titers were apparent between thymectomized 
and sham-thymectomized mice at 4 and 7 days after the initial injection of 10 or 
100  #g  of  (T,G)-A--L  (Figs.  1 a-2 b).  Both nonresponder  (C3H,  H-2  k)  and 
responder  (C3H.SW,  H-2  b)  mice reacted  to  the initial antigen challenge by 
producing  early antibody which  was  sensitive  to  treatment  with  2-Me  and 
which had been previously identified in intact mice as IgM antibody (2). 
Sham-thymectomized H-2  b mice (responder) reacted differently to secondary 
and tertiary antigen challenges than did (a)  their thymectomized counterparts, 
(b)  thymectomized H-2  k mice, and (c)  sham-thymectomized I-I-2  k mice. High 
titer  anti  (T,G)-A--L  antibodies  were  present  in  sham-thymectomized re- 
sponder mice after  100 #g secondary and tertiary challenges, and  the  l0 #g 
tertiary challenge. This antibody was resistant to treatment with 2-Me and was, 
therefore,  presumptively  IgG immunoglobulin. The increase in titer in these 
sham-thymectomized H-2  b mice is significant even though group sizes are small 
(e.g., at day 17 in Fig. 2 b, the response in three sham-thymectomized C3H.SW 
mice was 48 ±7%  compared with 7 4-2%  in  three  thymectomized C3H.SW 
mice [P --= 0.05]).  Sham-thymectomized H-2  ~ mice not only failed to produce 
2-Me-resistant  antibody, but  they also failed to produce another pulse of 2- 
Me-susceptible antibody. 
Influence of Adult Thymectomy Combined with Irradiation or Neonatal Thymec- 
tomy on  the Secondary Response  to  (T,G)-A--L in Adjuvant.--McDevitt  and 
Tyan have demonstrated that antibody responses to (T, G)-A--L are markedly 
reduced in  thymectomized syngeneic radiation  chimeras  of  the  "responder" 
strain C57BL/6 (H-2  b)  (4). The data presented in Table I  confirm and extend 
this observation. Neonatally thymectomized CWB/8 (H-2  ~) mice, unlike neona- 
tally sham-thymectomized CWB/8 mice,  respond  feebly to  aqueous booster 
injections after priming with (T, G)-A--L in Freund's adjuvant (experiment 1). A 
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Fro. 1.  The response of adult thymectomized or sham-thymectomized mice to  10/ag of 
aqueous (T,G)-A--L given intraperitoneally on days 0, 8, and 39: (e) C3H mice; (b)  C3H.SW 
mice.  Sham-thymectomized  total  antibody,  --O--;  sham-thymectomized  2-Me-resistant 
antibody,  ---O---;  thymectomized  total  antibody,  --e--;  thymectomized  2-Me-resistant 
antibodv,____~ --- •---. 
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FIo. 2.  The response of adult thymectomized or sham-thymectomized mice to 100 pg of 
aqueous (T,G)-A--L given intraperitoneally on days 0, 8, and 39: (a) C3H  mice;  (b)  C3H.SW 
mice.  Sham-thymectomized  total  antibody,  --O--;  sham-thymectomized  2-Me-resistant 
antibody,  ---O---;  thymectomized  total  antibody,  --0--;  thymectomized  2-Me-resistant 
antibody, --- •---. 
Reprinted by copyright permission from Ann. N. Y. Acad. Sci. 197l. 190. 
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A  similar  effect  of  thymectomy  was  noticed  in  adult  thymectomized,  bone 
marrow-protected  mice of the C57BL/10Sn (H-2 b) strain injected with antigen 
according to a similar regimen (experiment 2). 
In a third experiment, CBA/J (I-I-2 k, nonresponder) mice produced high titer 
antibody against  (T,G)-A--L provided  that  the  primary  (in  Freund's  adju- 
vant)  and secondary  challenges consisted  of MBSA-(T, G)-A--L.  The data in 
experiment  3 indicate  that adult  thymectomy combined  with irradiation pre- 
vents the conversion, by (T, G)-A--L complexed with MBSA, of nonresponder 
CBA mice to responder status. 
TABLE  I 
Influence  of Thymectomy  on the Secondary Response  to  (T, G)-A--L in Adjuvant 
Ex  o 
peri- 
ment 
x,To.  * 
Operation 
Neonatal  thymectomy 
Sham neonatal  thymec- 
tomy 
Thymectomy at 5 wk, 850 
R  and 4  X  106 syngeneic 
marrow cells i.v. 3-5 wk 
later 
Sham-thymectomy at 5 wk 
880 R  and 4  >(  l0 s syn- 
geneic marrow cells i.v. 
3-5 wk later 
Thymectomy at 5 wk, 850 
R  and 4  X  106 syngeneic 
marrow  cells  i.v.  4  wk 
later 
Sham thymectomy at 5 wk 
850  R  and  4  X  10~  syn- 
geneic marrow cells i.v. 4 
wk later 
Strain and 
H-2 type 
CWB/8  (11-2  b 
CWB/8  (H-2  ~' 
C57BL/10Sn 
(H-2  b) 
C57BL/10Sn 
(H-.~  ~) 
CBA/J  (H-2  k) 
CBA/J  (11-2  k) 
Sex 
M+F 
M+F 
M 
M 
M 
Age~  Antigen 
u'k 
6  (T, G)-A--L 
6  (T, G)-A--L 
6-9  (T, G)-A--L 
6-9  (T, G)-A--L 
10  (T, G)-A--L 
plus MBSA 
10  (T, G)-A--L 
plus MBSA 
No.  Antibody 
of  responses§  mice 
5  5.0  4-  1.3 
6  68.7  4-  7,8 
6.8  4-  4.8 
85.0  4-  6.3 
6.9  4-  2.7 
64.6  4-  4.8 
* In experiment  1, mice were injected with 10/*g (T, G)-A--L 509 in CFA to footpads and i.p., and 18 days 
later with 10 ~g aqueous  (T, G)-A--L 509 to footpads and i.p. Antibody titers were determined on sera obtained 
10  days  after  the  booster using labeled  (T, G)-A--L  at 0.01  ug/ml  and a  serum  dilution of  1/280.  Mice were 
injected  two  times more at 3 week intervals with aqueous  (T, G)-A--L and titers  (at 8 days after the second 
boost and 6 days after the third boost)  did not differ significantly from those above. In experiment 2 mice were 
injected with 10 ug (T,  G)-A--L 509 in  CFA to footpads  and i.p., and 21 days  later with 10/~g aqueous  (T, G)- 
A--L 509 to footpads and i.p. Titers were determined 10 days later using labeled (T, G)-A--L at 0.08 ~g/ml and a 
serum dilution of  1/280.  In  experiment 3, mice were injected  with 100/*g (T, G)-A--L 82 complexed with 100/,g 
MBSA in CFA to footpads, and 21 days later with 100/~g each in aqueous solution. Titers were determined 10 days 
later using labeled (T, G)-A--L at 0.01/*g/ml and a  serum  dilution of 1/50. 
Age or time after irradiation and marrow injection in the case of radiation chimeras. 
§ Per cent labeled antigen bound (±SE). All differences are highly significant (P <  0.008). 132  GENETIC  CONTROL  OF  THE  IMMUNE  RESPONSE:  THYMECTOMY 
DISCUSSION 
The genetically  controlled  immune response  to  (T,G)-A--L appears  to be 
thynms dependent on the basis of three lines of evidence. First, adult thynlec- 
tomy (combined with X-irradiation and bone marrow transfusion)  or neonatal 
thymectomy  ablate the response of (high) responder H-2  b mice immunized with 
(T,G)-A-L in adjuvant, confirming and extending earlier reports  (4). Second, 
adult thymectomy also ablates the otherwise high response of "nonresponder" 
H-2  k mice to MBSA-(T, G)-A--L in adjuvant. Third, when aqueous antigen is 
used for immunization,  thymectomy  selectively blocks the H-2  b responder mice 
switchover from IgM to IgG antibody formation (after secondary  or tertiary 
antigen challenge).  The primary IgM anti-(T, G)-A--L response in both re- 
sponder and nonresponder  mice is not a function of H-2 type and is unaffected 
by thymectomy. 
Hypotheses concerning the nature of the genetic control exerted by the Ir-1 
gene nmst now take into consideration the results reported here and those of the 
preceding paper,  (2)  as well as the recent demonstration that the binding  of 
125I-labeled (T, G)-A--L by unimmunized spleen cells is equal in responder, non- 
responder,  and congenitally  athymic mice (N.  Warner,  personal  communica- 
tion). 
We wish to consider two mechanisms at the cellular level which could account 
for the available data:~ 
(a)  Bone marrow-derived B-cells of the IgM type (B") could bind  and re- 
spond  to antigen in the absence of any thymus-derived T-cell  influence. By 
contrast, B-cells of the IgG type (B y) might bind antigen, but would require an 
influence of reactive  or antigen-activated T-cells to be triggered into antibody 
production. Perhaps B"-cells switch to B ~ ceils and this conversion of expression 
of imnmnoglobulin constant region genes in the B-cell line is mediated, directly 
or indirectly, by T-cells. Alternatively, proper presentation of antigen by T-cells 
could be required for triggering antibody production by predetermined B ~-cells 
(but not B"-cells). The latter possibility might reflect differences in avidity and, 
therefore,  activating  efficiency of  antigen  binding  to  receptors  on  B~-  and 
B ~-cells. 
(b) Thymectomy and X-irradiation may not completely purge T-cells from 
peripheral lymphoid organs. (Support for this supposition could be provided  by 
a demonstration that primary and/or secondary antibody response patterns in 
either congenitally athymic mice, or in adoptive experiments using cell popula- 
tions proven to be completely devoid of T-cells, are different from those of mice 
Interpretation  of  many  aspects  of  the  genetic  control  of  the  immune  response  to 
(T,G)-A--L relies heavily upon recent findings of T- and B-cell interactions in responses of 
irradiated  and thymectomized mice immunized with SRBC  (5). Although there is no proof 
that cellular events in the immune response to  (T,G)-A--L are identical to those of heterolo- 
gous red cells or proteins, it will be assumed that the same qualitative mechanisms pertain, and 
that anti-(T,G)-A--L antibody production is in the province of B- and not T-cells. G.  F.  MITCHELL,  ]?.  C.  GRUMET,  AND  H.  O.  MEDEVITT  133 
subjected to adult thymectomy, X-irradiation, and bone marrow transfusion.) 
The reactive T-cells, though decreased in number, could still facilitate triggering 
or expression of a relatively few B-cells. If B"-cells predominated, then more of 
these would be recruited than would B~-cells. In the presence of reduced levels 
of inhibitory IgG antibody, clonal expansion of the triggered B,-cells would be 
accelerated. Thus IgM levels might be similar in this situation and that in which 
larger numbers of T-cells were present. In the latter case,  more B~-ceUs and 
BY-cells could be triggered, but the clonal expansion of the B,-cells would be 
restricted by the appearance of early IgG antibody produced by the B~-cells. 
Other indirect evidence supports the contention that in both responder and 
nonresponder mice, the B-cell populations are equally capable of synthesizing 
potent anti-(T,G)-A--L antibodies, whereas the T-cells show differential re- 
activity to that immunogen (1, 4,  14).  Nonresponder mice may thus be con- 
sidered to possess a functional or cognitive lesion in their T-cell population with 
respect to the carrier moiety of the (T, G)-A--L immunogen. This could produce 
the observed diminished secondary antibody response on the part of an other- 
wise competent B-cell population. The functional T-cell lesion  could be  by- 
passed when the polypeptide is complexed to a new "recognizable" carrier such 
as MBSA; and this new immunogen thus could convert the nonresponder to a 
responder status. It is apparent from the data in Table I that this conversion to 
responder status can be reversed by thymectomy, implying that the MBSA 
carrier was able to circumvent the (T,G)-A--L-specific functional lesion, but 
not the surgical lesion in T-populations. 
No IgM memory could be demonstrated in the present system. In all C3H 
mice and thymectomized C3H.SW mice, secondary and tertiary antigen chal- 
lenges failed to elicit any further antibody response. We have not yet deter- 
mined the mechanism of this tolerance or paralysis. It is possible that B-cells, in 
the absence of reactive T-cells, undergo an abortive response resulting in ulti- 
mate  exhaustion  and  thus tolerance at the B-cell level.  Alternatively, it  is 
possible that the tolerance/paralysis is the result of an active process mediated 
by a cellular or humoral negative feedback mechanism. As in the case of intact 
nonresponder mice, resolution of this problem must await further studies in- 
volving cell transfers. 
The minimal predictions put forth earlier, i.e. that thyrnectomy should con- 
vert responder mice to a  nonresponder pattern of anti-(T, G)-A--L antibody 
formation without affecting the pattern of the nonresponder, have been fulfilled 
by the data presented. These results are consistent with the hypothesis that the 
Ir-1 gene effect is mediated via T-cells acting during the stage of induction of 
IgG antibody formation. 
SUMMARY 
The  effect of  thymectomy on  the  genetically controlled routine immune 
responsed (Ir-l)  to the synthetic polypeptide poly-L(Tyr,  Glu)-poly-D, L-Ala-- 134  GENETIC  CONTROL  OF  THE  IMMUNE  RESPONSE:  THYMECTOIVfY 
polyq~-Lys [(T, G)-A--L] was studied with both aqueous and adjuvant immuni- 
zation regimens.  Adult  thymectomy  (combined  with  irradiation  and  bone 
nlarrow transfusion) did not affect the aqueous antigen-induced (IgM) primary 
response of either  high  or low responder mice,  but  did  ablate  the  (IgG)  sec- 
ondary or tertiary response, a response which is restricted to the high responder 
strains. Adult thymectomy also  blocked the  normal  high response  to (T,G)- 
A--L in  Freund's  adjuvant in  high responder mice and  the high response  to 
methvlated bovine serum albumin (MBSA)-(T,G)-A--L in low resp~nder mice. 
Neonatal thymectomywas also  effective  in  blocking  the  response  to (T,G)- 
A--L  in Freund's adjuvant in high re,ponder mice. 
These  data  are  consistent  with  the  concept  that  the  Ir-1  gene  effect 
is mediated via thymus cell interaction with antigen and with "B"-cells during 
the time of induction of IgG antibody formation. 
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